Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C049325 |
1,2-dithiol-3-thione |
1,2-dithiol-3-thione results in increased expression of TUBB3 mRNA | increases expression | 15302862
|
C075773 |
4-phenylbutyric acid |
[4-phenylbutyric acid affects the acetylation of HDAC1 protein] which affects the expression of TUBB3 protein | affects acetylation|affects expression | 18497984
|
C075773 |
4-phenylbutyric acid |
[4-phenylbutyric acid affects the acetylation of MECP2 protein] which affects the expression of TUBB3 protein | affects acetylation|affects expression | 18497984
|
C075773 |
4-phenylbutyric acid |
4-phenylbutyric acid affects the expression of TUBB3 protein | affects expression | 18497984
|
C075773 |
4-phenylbutyric acid |
[decitabine co-treated with 4-phenylbutyric acid] affects the expression of TUBB3 protein | affects cotreatment|affects expression | 18497984
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of TUBB3 mRNA | affects expression | 17562736
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of TUBB3 mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of TUBB3 protein | decreases expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of TUBB3 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of TUBB3 mRNA | decreases expression | 20382639
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased expression of TUBB3 mRNA | increases expression | 16772336
|
C018021 |
cobaltous chloride |
cobaltous chloride results in increased expression of TUBB3 protein | increases expression | 16772336
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of TUBB3 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine affects the expression of TUBB3 mRNA | affects expression | 18497984
|
C014347 |
decitabine |
decitabine affects the expression of TUBB3 protein | affects expression | 18497984
|
C014347 |
decitabine |
[decitabine co-treated with 4-phenylbutyric acid] affects the expression of TUBB3 protein | affects cotreatment|affects expression | 18497984
|
D003676 |
Deferoxamine |
Deferoxamine results in increased expression of TUBB3 mRNA | increases expression | 16772336
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TUBB3 mRNA | affects cotreatment|decreases expression | 16054899
|
D004642 |
Emodin |
Emodin results in decreased expression of TUBB3 mRNA | decreases expression | 16045814
|
D004958 |
Estradiol |
Estradiol results in increased expression of TUBB3 mRNA | increases expression | 19466750
|
D004958 |
Estradiol |
Estradiol results in increased expression of TUBB3 protein | increases expression | 19466750
|
D004958 |
Estradiol |
fulvestrant inhibits the reaction [Estradiol results in increased expression of TUBB3 mRNA] | decreases reaction|increases expression | 19466750
|
D004958 |
Estradiol |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of TUBB3 mRNA] | decreases reaction|increases expression | 19466750
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of TUBB3 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUBB3 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of TUBB3 mRNA | increases expression | 17108234
|
C070081 |
fulvestrant |
fulvestrant inhibits the reaction [Estradiol results in increased expression of TUBB3 mRNA] | decreases reaction|increases expression | 19466750
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of TUBB3 mRNA | increases expression | 16221962
|
D017313 |
Fenretinide |
Fenretinide results in increased expression of TUBB3 protein | increases expression | 17110918
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TUBB3 mRNA | affects cotreatment|decreases expression | 16054899
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate affects the expression of TUBB3 mRNA | affects expression | 19615344
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of TUBB3 mRNA] | decreases expression|decreases reaction | 19615344
|
C073402 |
PD 123319 |
PD 123319 inhibits the reaction [AGT protein results in increased expression of TUBB3 protein] | decreases reaction|increases expression | 17068200
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TUBB3 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of TUBB3 mRNA | increases expression | 15302862
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of TUBB3 mRNA | affects cotreatment|decreases expression | 16054899
|
C010327 |
salinomycin |
salinomycin results in decreased expression of TUBB3 mRNA | decreases expression | 19682730
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of TUBB3 mRNA | increases expression | 20308225
|
C017947 |
sodium arsenite |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of TUBB3 mRNA] | decreases expression|decreases reaction | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of TUBB3 mRNA | decreases expression | 19615344
|
D013629 |
Tamoxifen |
Tamoxifen inhibits the reaction [Estradiol results in increased expression of TUBB3 mRNA] | decreases reaction|increases expression | 19466750
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TUBB3 mRNA | increases expression | 20106945
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of TUBB3 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of TUBB3 mRNA | increases expression | 17942748
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TUBB3 protein | increases expression | 16646664
|
D014212 |
Tretinoin |
AKT1 protein inhibits the reaction [Tretinoin results in increased expression of TUBB3 protein] | decreases reaction|increases expression | 16613989
|
D014212 |
Tretinoin |
DKK1 protein promotes the reaction [Tretinoin results in increased expression of TUBB3 protein] | increases expression|increases reaction | 17064353
|
D014212 |
Tretinoin |
FGF2 protein promotes the reaction [Tretinoin results in increased expression of TUBB3 protein] | increases expression|increases reaction | 16009726
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of TUBB3 protein | increases expression | 16009726 17064353 16613989
|
D014303 |
Trinitrotoluene |
Trinitrotoluene affects the expression of TUBB3 mRNA | affects expression | 21346803
|
D014635 |
Valproic Acid |
Valproic Acid affects the expression of TUBB3 protein | affects expression | 19460635
|
C081489 |
valsartan |
valsartan promotes the reaction [AGT protein results in increased expression of TUBB3 protein] | increases expression|increases reaction | 17068200
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
12.68 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Trinitrotoluene |
12.68 | 7525203 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
12.68 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.68 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.28 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.66 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.86 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.57 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.57 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
9.57 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fenretinide |
9.57 | 10697514 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.49 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.97 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.62 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.40 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.79 | 19621015 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
4.95 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.56 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.35 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.80 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.19 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
11.29 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.29 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
11.29 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.20 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.26 | 16456186 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.58 | 11514358 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.85 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.85 | 18396377 15238991 16609825 20603192 18775368 18985861 19232924 18558336 18177632 18940202 17688650 17507914 19460635 18316065 17157402 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.14 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.94 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
13.82 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
13.82 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
13.82 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.43 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.43 | 8888407 |
MESH:D001932 |
Brain Neoplasms |
|
Fenretinide |
4.11 | 16187019 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
6.70 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
6.70 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Deferoxamine |
6.70 | 15993339 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
6.70 | 17261762 16675129 17018787 12948864 19861407 17289903 18497071 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Fenretinide |
6.70 | 16601279 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
6.70 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
salinomycin |
6.70 | 19682730 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
6.70 | 17440819 19289846 19189210 21138602 15565566 19200415 18815881 16818667 19011961 17049068 17893378 17242785 19221464 19487384 15668708 19103187 20859285 18629630 16873071 18997820 19189212 19410462 19115204 18821012 19084267 19155303 20544844 18984771 20390343 19142967 18425577 19244106 20135344 19059307 20065188 18855134 18351453 19288272 16273361 19066611 11161223 21152245 20005174 16202921 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
6.70 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
6.70 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.31 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.18 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.58 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.23 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.87 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
10.75 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.75 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fenretinide |
10.75 | 16270382 17159502 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
10.75 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
10.75 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
10.75 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
13.43 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
13.43 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fenretinide |
13.43 | 16274795 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
13.43 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
13.43 | 16051514 16096774 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.37 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.61 | 18850075 18670907 16120746 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
6.61 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.26 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
4.11 | 11230374 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
11.46 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
11.46 | 17460283 |
MESH:D002386 |
Cataract |
|
Trinitrotoluene |
11.46 | 14694615 15817613 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
14.45 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
14.45 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.45 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.45 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Fenretinide |
12.04 | 16154183 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
12.04 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.61 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
12.16 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.16 | 16919318 11677210 16105132 17333356 17681005 15861022 17110522 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.16 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.87 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.37 | 15668235 16354765 12621046 8697196 15340226 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.37 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.43 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.78 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
3.78 | 15824018 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.82 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fenretinide |
2.82 | 17273769 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
8.50 | 17141729 14669216 |
MESH:D000013 |
Congenital Abnormalities |
|
Trinitrotoluene |
8.50 | 15095906 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.80 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.56 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
5.14 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.14 | 10048152 20055451 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.14 | 8800419 17551590 9664655 16925845 9125849 10589399 14991402 9142499 9224671 9211117 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.14 | 17688650 8888407 16575769 |
MESH:D003490 |
Cyanosis |
|
Trinitrotoluene |
4.65 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.09 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
cobaltous chloride |
6.60 | 15059100 16823706 11298694 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
6.60 | 12438553 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.07 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.37 | 11508273 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
4.25 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.25 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.79 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.79 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
13.79 | 11427623 18630688 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.44 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
11.10 | 14725611 17522070 17906064 10663392 16781746 10774834 12705907 19370779 19739265 12958197 19416960 12594235 18713872 17562736 10915739 19164858 11461765 19420014 11287661 16485898 12153990 14986274 18071297 16109766 11834606 12392966 19923254 11529661 16227642 12540782 11743745 19085960 15619225 14550746 16393943 16177239 2444490 11421492 16081117 15968718 11739529 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
11.10 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.10 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trinitrotoluene |
11.10 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.10 | 1733752 19641884 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.81 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.56 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.79 | 1851702 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.19 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
14.43 | 19703484 |
MESH:D004487 |
Edema |
|
pirinixic acid |
14.43 | 12083418 |
MESH:D004487 |
Edema |
|
rosiglitazone |
14.43 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
14.43 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.00 | 16714409 18230668 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.00 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
8.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.06 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.83 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
11.38 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
11.38 | 16202921 19155303 20544844 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
11.38 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.78 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.88 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.63 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.79 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.36 | 7562514 6254150 6426943 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.02 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.79 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.10 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.10 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.15 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.15 | 9664655 16938888 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
27.47 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
27.47 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
27.47 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
27.47 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
27.47 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
27.47 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.07 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.60 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.86 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.90 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
24.86 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Emodin |
24.86 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
24.86 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
24.86 | 17994277 |
MESH:D005355 |
Fibrosis |
|
valsartan |
24.86 | 16893502 |
OMIM:600638 |
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR INVOLVEMENT |
marker/mechanism |
|
| |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.39 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.40 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.94 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Fenretinide |
6.84 | 16187019 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.84 | 17312396 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.28 | 16928621 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
7.21 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.21 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.87 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.23 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.23 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.23 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
6.82 | 20558911 |
MESH:D006333 |
Heart Failure |
|
valsartan |
6.82 | 19027736 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.14 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
18.49 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
18.49 | 19176532 18467677 16221962 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
18.49 | 12621046 16120746 15340226 |
MESH:D006529 |
Hepatomegaly |
|
Trinitrotoluene |
18.49 | 15817613 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.97 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.75 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.93 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.47 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.59 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 16959395 16354765 18606429 8697196 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
11.83 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
11.83 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
11.83 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.29 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.94 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
11.53 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
11.53 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
11.53 | 18850075 18670907 |
MESH:D006973 |
Hypertension |
|
valsartan |
11.53 | 20102058 18344623 16475468 18390891 12850387 12692753 11427623 10903974 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.13 | 11560862 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.54 | 16945680 16569931 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.16 | 18306037 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.20 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
19.17 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
19.17 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
19.17 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
19.17 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
Trinitrotoluene |
19.17 | 12150543 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
10.80 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
10.80 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
10.80 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
10.80 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.34 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.34 | 16306350 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
11.34 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.49 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.10 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.10 | 17551590 15992940 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.16 | 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
17.36 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
17.36 | 18776723 8314463 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
17.36 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
17.36 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
17.36 | 10903974 16893502 12164870 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.07 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.07 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.07 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
5.96 | 18980019 19235587 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
5.96 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Emodin |
4.77 | 17077332 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
8.73 | 18454857 19117987 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
8.73 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
8.37 | 19010910 18704418 19387464 18460780 18206229 17679729 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Deferoxamine |
8.37 | 20368581 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.37 | 16294345 17596541 19850784 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
8.37 | 17596541 16294345 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.18 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
2.97 | 17361223 17368321 17294898 17107899 17301526 15748426 16823087 19642359 16935935 17506722 16891316 19029980 17649720 16140955 16788101 12679006 19075265 9834237 16766008 17339181 19035177 16331271 17217047 19225113 17712046 |
MESH:D007972 |
Leukoplakia, Oral |
|
Fenretinide |
5.76 | 16707609 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.11 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.96 | 17567588 15342952 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
14.97 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Emodin |
14.97 | 15288473 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
14.97 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
14.97 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
14.97 | 17347453 15980055 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
14.97 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
14.97 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
14.97 | 18397230 16248980 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
14.97 | 16872305 15619341 15504291 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.56 | 19014921 12969438 19460945 16611625 12587719 19784758 16610002 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
2.99 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
13.06 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.06 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.06 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.06 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.06 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
1.94 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.99 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
3.98 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.19 | 20064080 18520028 20869020 20464547 18569708 17053015 18816296 20135361 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
6.19 | 15824018 11195469 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.19 | 17077188 17306315 16712894 19931552 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.19 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.19 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.22 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.48 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
16.97 | 17203775 16891317 11408345 11807958 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Fenretinide |
16.97 | 10697514 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
16.97 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
salinomycin |
16.97 | 19682730 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
16.97 | 11731420 19196722 14580682 19196723 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.70 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.70 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.67 | 17453147 |
MESH:D008545 |
Melanoma |
|
decitabine |
9.23 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Fenretinide |
9.23 | 16270382 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.23 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
9.23 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.23 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.90 | 15990972 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.29 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.15 | 16940565 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.15 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.50 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
2.99 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
8.08 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fenretinide |
8.08 | 16274795 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.87 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
6.87 | 16118317 15744524 15867202 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.23 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.78 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
16.28 | 16882708 19010910 19157545 18608210 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
16.28 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
16.28 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
16.28 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.03 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.80 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.55 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.55 | 16411023 |
MESH:D009336 |
Necrosis |
|
Trinitrotoluene |
4.49 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.44 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
4-phenylbutyric acid |
21.91 | 19116145 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
21.91 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
21.91 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
Fenretinide |
21.91 | 17353921 15958647 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
21.91 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
21.91 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
21.91 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.39 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.72 | 19189210 19196722 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.45 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.05 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.79 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.79 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
14.79 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
11.11 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
11.11 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
11.11 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.65 | 18514411 |
MESH:D009472 |
Neuronal Ceroid-Lipofuscinoses |
|
Fenretinide |
5.40 | 16303764 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
Trinitrotoluene |
4.10 | 14694615 17852074 12819281 |
MESH:D010051 |
Ovarian Neoplasms |
marker/mechanism |
|
| 18497984 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
14.01 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.01 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Fenretinide |
14.01 | 16133793 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
14.01 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.01 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.85 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
5.85 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
8.17 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fenretinide |
8.17 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
8.17 | 15976015 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.43 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.99 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
3.39 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.53 | 11399792 11896295 11222880 11118676 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
8.53 | 20603192 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.45 | 17616702 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fenretinide |
1.89 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
8.73 | 16636307 |
MESH:D011507 |
Proteinuria |
|
valsartan |
8.73 | 12164870 18344623 17664856 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.03 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.26 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.13 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.51 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.71 | 17241526 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.25 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
3.76 | 18379247 11700416 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
Fenretinide |
4.20 | 16303925 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
17.02 | 19155313 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
17.02 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
17.02 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.03 | 19110320 15737665 |
MESH:D012640 |
Seizures |
|
Trinitrotoluene |
5.66 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.66 | 11738929 14763951 17978042 3137016 1511512 16876388 15475178 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
16.52 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Fenretinide |
16.52 | 16467112 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.52 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.52 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
16.52 | 16467112 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.61 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.61 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.76 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
8.84 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
8.84 | 19490988 |
MESH:D013163 |
Splenomegaly |
|
Trinitrotoluene |
4.93 | 15817613 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.26 | 12833885 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.04 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.21 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.21 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.21 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.25 | 15138204 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.36 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.92 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.60 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.60 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.40 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.55 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
4.95 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.06 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.24 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
14.62 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
14.62 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Fenretinide |
14.62 | 16720286 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.62 | 16712894 16452187 11723127 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.62 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.37 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
2.72 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fenretinide |
14.56 | 16154183 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.56 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
14.56 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.03 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
11.88 | 17785578 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
11.88 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.82 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.82 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.14 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.29 | 15869587 14671159 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.42 | 19027736 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.79 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.73 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.16 | 17120751 |